Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Synthetic hair fibers for hair restoration were controversial in 2009 due to health risks and lack of support from the International Society of Hair Restoration.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Lower testosterone levels may increase heart failure risk in older men.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Actinic keratosis is more common in older men with certain genetic traits, but smoking seems to reduce its odds.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Isotretinoin is safe and effective for acne, with common side effects like dry lips; serious side effects are rare.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

New genes found linked to balding, may help develop future treatments.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

WNT10A and EBF1 interaction affects hair growth in male-pattern baldness.